$SWIM

Latham Group, Inc. (SWIM) will release Q3 2026 earnings on Nov. 3, 2026, after market close. A conference call is scheduled for 4:30 PM ET. The company is the largest designer and manufacturer of in-ground residential pools in North America, Australia, and New Zealand, with 1,900 employees across 35 locations.

Latham (SWIM) raised full-year guidance, with its stock up 12.2% to $6.40. Smith & Wesson (SWBI) reported $112.6M revenue, up 32.3%, and its stock rose 19.6% to $14.67. Brunswick (BC) reported $1.56B revenue, up 7.7%, but its stock fell 19.4% to $64.86. Polaris (PII) reported $2.04B revenue, up 8.7%, but its stock dropped 26.3% to $55.07. Ruger (RGR) reported $158.1M revenue, up 19.3%, and its stock rose 17.7% to $44.48.

Epiris LLP will acquire Gamma Communications PLC for £1.015 billion ($1.374 billion), taking the U.K. telecommunications company private, according to the firms. The deal was announced Tuesday.

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

Latham Group (SWIM) secured $375 million in new credit facilities, including a $75 million revolving credit line and a $300 million term loan, led by Jefferies Finance. The facilities will refinance and extend the company's maturities, replacing a 2022 Barclays-led agreement. The revolver matures in 2031, and the term loan in 2033.

Latham Group, Inc. (SWIM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 20, 2026 (the “Closing Date”), certain subsidiaries of Latham Group, Inc. (the “Company”) entered into the Credit Agreement (the “Credit Agreement”) and the Loan Guaranty, each by and among Latham Pool Products, Inc.

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

Analysts cited bullish views on industrial and technology stocks. BTIG reiterated a Buy on V2X (VVX) with a $90 target versus a $78.76 close, and TipRanks consensus targets $89.30. Clear Street reiterated a Buy on Red Cat Holdings (RCAT) with a $19 target versus $8.86 close. Stifel reiterated Buy on Latham Group (SWIM) with a $9.50 target versus $5.70 close.

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.